i-gel® from Intersurgical: clinical evidence listing

A comprehensive list of all known published clinical evidence on the device

Assessment of suitability of i-gel and laryngeal mask airway-supreme for controlled ventilation in anesthetized paralyzed patients: A prospective randomized trial

Radhika KS, Sripriya R, Ravishankar M, Hemanth Kumar VR, Jaya V, Parthasarathy S. Anesth Essays Res. 2016;10(1):88-93

Patients were split into i-gel and LMA Supreme groups, with insertion attempts, time and any manoeuvres needed forming outcomes, along with peak inspiratory pressure (PIP).  LMA-S was inserted successfully in more patients, but with no significant difference in PIP.

Link to abstract

Application of the LMA-Supreme™ and i-gel™ laryngeal masks during pelvic operations in adults

Wang F, Zhang R. Asian J Surg. 2016 Jan;39(1):1-5

90 patients divided into two groups, i-gel and LMA Supreme. Latter group required less time to insertion and gastric tube indwelling time, but i-gel group had fewer complications. Authors conclude both devices are safe and effective for this procedure.

Link to abstract

Complications Associated with the Use of Supraglottic Airway Devices in Perioperative Medicine

Michalek P, Donaldson W, Vobrubova E, Hakl M. Biomed Res Int. 2015; 2015: 746560

Review highlighting the complications that may arise from the use of supraglottic airways, including aspiration and regurgitation of gastric contents, compression of vascular structures and nerve injury.

Link to abstract

Third generation supraglottic airway devices: an undefined concept and misused term. Time for an updated classification of supraglottic airway devices

Cook TM. Br J Anaesth. 2015 Oct;115(4):633-4

Letter to the editor recommending that the term 'third generation' used when describing supraglottic airway devices is abandoned due to the confusion over the design features that determine the device's advancement. The author makes further suggestion as to how devices should be classified.

Link to abstract